Common genetic variants in platelet surface receptors and its association with ischemic stroke

Lukasz Milanowski, Justyna Pordzik, Piotr Janicki, Marek Postula

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Ischemic stroke has been named one of the leading causes of death worldwide. Whereas numerous biological mechanisms and molecules were found to be associated with stroke, platelets are particularly contributive to its pathogenesis. Recent data indicate considerable variability in platelet phenotype which accounts for differences in platelet surface receptor function, count and reactivity. These features collectively influence both the events leading to a disease and effectiveness of antiplatelet therapies. Consequently, genetic variants predisposing to cerebrovascular diseases can be sequenced using a wide array of techniques and become a useful tool in clinical setting. In this review, we provide an outline of common platelet polymorphisms that impose risk on ischemic stroke development and should be evaluated as targets to improve treatment. As study results are often inconsistent, partly due to differences in demographic characteristics between study populations and the fact that the functional impact of these variants has been relatively small, we conclude that both rare, low-frequency and common variants might account for genetic contribution on abnormal platelet response to antiplatelet drugs.

Original languageEnglish (US)
Pages (from-to)953-971
Number of pages19
JournalPharmacogenomics
Volume17
Issue number8
DOIs
StatePublished - Jun 1 2016

Fingerprint

Blood Platelets
Stroke
Cerebrovascular Disorders
Platelet Aggregation Inhibitors
Cause of Death
Demography
Phenotype
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Milanowski, Lukasz ; Pordzik, Justyna ; Janicki, Piotr ; Postula, Marek. / Common genetic variants in platelet surface receptors and its association with ischemic stroke. In: Pharmacogenomics. 2016 ; Vol. 17, No. 8. pp. 953-971.
@article{3ce5c4f51cd24a56adf37f6450d279af,
title = "Common genetic variants in platelet surface receptors and its association with ischemic stroke",
abstract = "Ischemic stroke has been named one of the leading causes of death worldwide. Whereas numerous biological mechanisms and molecules were found to be associated with stroke, platelets are particularly contributive to its pathogenesis. Recent data indicate considerable variability in platelet phenotype which accounts for differences in platelet surface receptor function, count and reactivity. These features collectively influence both the events leading to a disease and effectiveness of antiplatelet therapies. Consequently, genetic variants predisposing to cerebrovascular diseases can be sequenced using a wide array of techniques and become a useful tool in clinical setting. In this review, we provide an outline of common platelet polymorphisms that impose risk on ischemic stroke development and should be evaluated as targets to improve treatment. As study results are often inconsistent, partly due to differences in demographic characteristics between study populations and the fact that the functional impact of these variants has been relatively small, we conclude that both rare, low-frequency and common variants might account for genetic contribution on abnormal platelet response to antiplatelet drugs.",
author = "Lukasz Milanowski and Justyna Pordzik and Piotr Janicki and Marek Postula",
year = "2016",
month = "6",
day = "1",
doi = "10.2217/pgs.16.21",
language = "English (US)",
volume = "17",
pages = "953--971",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "8",

}

Common genetic variants in platelet surface receptors and its association with ischemic stroke. / Milanowski, Lukasz; Pordzik, Justyna; Janicki, Piotr; Postula, Marek.

In: Pharmacogenomics, Vol. 17, No. 8, 01.06.2016, p. 953-971.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Common genetic variants in platelet surface receptors and its association with ischemic stroke

AU - Milanowski, Lukasz

AU - Pordzik, Justyna

AU - Janicki, Piotr

AU - Postula, Marek

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Ischemic stroke has been named one of the leading causes of death worldwide. Whereas numerous biological mechanisms and molecules were found to be associated with stroke, platelets are particularly contributive to its pathogenesis. Recent data indicate considerable variability in platelet phenotype which accounts for differences in platelet surface receptor function, count and reactivity. These features collectively influence both the events leading to a disease and effectiveness of antiplatelet therapies. Consequently, genetic variants predisposing to cerebrovascular diseases can be sequenced using a wide array of techniques and become a useful tool in clinical setting. In this review, we provide an outline of common platelet polymorphisms that impose risk on ischemic stroke development and should be evaluated as targets to improve treatment. As study results are often inconsistent, partly due to differences in demographic characteristics between study populations and the fact that the functional impact of these variants has been relatively small, we conclude that both rare, low-frequency and common variants might account for genetic contribution on abnormal platelet response to antiplatelet drugs.

AB - Ischemic stroke has been named one of the leading causes of death worldwide. Whereas numerous biological mechanisms and molecules were found to be associated with stroke, platelets are particularly contributive to its pathogenesis. Recent data indicate considerable variability in platelet phenotype which accounts for differences in platelet surface receptor function, count and reactivity. These features collectively influence both the events leading to a disease and effectiveness of antiplatelet therapies. Consequently, genetic variants predisposing to cerebrovascular diseases can be sequenced using a wide array of techniques and become a useful tool in clinical setting. In this review, we provide an outline of common platelet polymorphisms that impose risk on ischemic stroke development and should be evaluated as targets to improve treatment. As study results are often inconsistent, partly due to differences in demographic characteristics between study populations and the fact that the functional impact of these variants has been relatively small, we conclude that both rare, low-frequency and common variants might account for genetic contribution on abnormal platelet response to antiplatelet drugs.

UR - http://www.scopus.com/inward/record.url?scp=84976514861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976514861&partnerID=8YFLogxK

U2 - 10.2217/pgs.16.21

DO - 10.2217/pgs.16.21

M3 - Review article

VL - 17

SP - 953

EP - 971

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 8

ER -